Rockefeller Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Rockefeller Capital Management's TWST Position: Q1 2026 in Review
Rockefeller Capital Management reduced its Twist Bioscience (TWST) stake by 25% in Q1 2026, selling an estimated $167K and leaving 11,253 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.
Rockefeller Capital Management first reported a position in TWST in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.9M in Q3 2021. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Rockefeller Capital Management held 11,253 shares of Twist Bioscience worth $535K as of Q1 2026.
- Rockefeller Capital Management sold 3,717 Twist Bioscience shares in Q1 2026, an estimated $167K.
- Twist Bioscience made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1943 holding.
- Rockefeller Capital Management first reported a position in Twist Bioscience in Q4 2020 and has held it in 14 quarters since.
- Rockefeller Capital Management's Twist Bioscience position peaked at $1.9M in Q3 2021.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.